Otoscreen

The WHO estimates that 1/4 of the global population will have hearing loss by 2050 and that even 80% will go undiagnosed. Otoscreen’s solution enables doctors to diagnose multiple hearing loss patients in just minutes. This will reform healthcare and save its resources.

Addressing hearing loss is crucial due to the expected rise in hearing loss cases, which could lead to a significant economic burden by 2050. Early identification of hearing loss is crucial for effective treatment, reducing costs and functional decline associated with the condition. This project explores solutions that result in earlier intervention. Benefits include efficiency, actionability, and reach, leading to improvements in quality of life, productivity and social inclusion.